Pituitary adenomas in man and mouse: Oncogenic potential of a truncated fibroblast growth factor receptor 4

Journal of Clinical Investigation

Volumn 109, Issue 1, 2002, Pages 15-16

  Low, Malcolm J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 4;

CARCINOGENESIS; CELL GROWTH; CLONAL ANERGY; GENE EXPRESSION REGULATION; GENETIC HETEROGENEITY; HUMAN; HYPOPHYSIS ADENOMA; NONHUMAN; NOTE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0036141378     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214772     Document Type: Note

References (12)

1. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas
2. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours
3. Positional cloning of the gene for multiple endocrine neoplasia-type 1
4. Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours
5. Isolation and characterization of a pituitary tumor-transforming gene (PTTG)
6. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis
7. Targeted expression of a human pituitary tumor-derived isoform of FGF receptor 4 recapitulates pituitary tumorigenesis
8. Altered expression of fibroblast growth factor receptors in human pituitary adenomas
9. Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice
10. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors
11. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling